Submitted:
15 November 2023
Posted:
16 November 2023
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Informed Consent Statement
Acknowledgments
Conflicts of Interest
Appendix A
- What is your age?
- –
- Numeric value
- What is your sex?
- –
- Female / Male
- Have you had COVID-19 or tested positive for COVID-19?
- –
- Yes / No
- Has any member of your family been sick with COVID-19 or tested positive for COVID-19?
- –
- Yes / No
- Do you belong to any of the vulnerable groups to COVID-19?
- –
- Yes / No / I don’t know
- How would you characterize your health status based on any diagnosed underlying diseases?
- –
- 7-point Likert scale: 1 = terrible, 2 = very bad, 3 = bad, 4 = moderate, 5 = good, 6 = very good, 7 = excellent
- Have you been vaccinated against COVID-19?
- –
- Yes / No
- Did you wear a mask properly, with your nose and mouth covered, indoors where required (e.g. in the supermarket, at work)?
- Did you wash your hands often and carefully / or did you apply antiseptic after touching potentially contaminated surfaces whenever possible (e.g. when returning home, at work)?
- Did you avoid crowded indoor spaces or places that require close contact between people?
- Did you avoid touching your eyes, nose and mouth, without washing your hands first?
- Did you prefer contactless payment methods (e.g. credit cards, mobile phone) over cash for your purchases?
- Did you avoid kisses, handshakes and hugs?
- Do you consider yourself a person who is willing to take risks? Please answer on a scale from 0 to 10, where 0 means "completely unwilling to take risks in general", and 10 means "completely willing to take risks in general".
- Do you consider yourself a person who is willing to take risks related to health? Please answer on a scale from 0 to 10, where 0 means "completely unwilling to take risks related to my health", and 10 means "completely willing to take risks related to my health".
- How worried are you about COVID-19?
- –
- 7-point Likert scale: 1 = Not worried at all – 7 = Extremely worried
- How likely do you think it is that you will get COVID-19 in the next six months?
- –
- 7-point Likert scale: 1 = Not at all likely – 7 = Extremely likely
- How likely do you think it is that your friends or relatives will be affected by COVID-19 in next six months?
- –
- 7-point Likert scale: 1 = Not at all likely – 7 = Extremely likely
- How much do you agree with the following statement: "COVID-19 will affect a large part of the population in our country"?
- –
- 7-point Likert scale: 1 = I strongly disagree – 7 = I strongly agree
- How much do you agree with the following statement: "COVID-19 can be serious"?
- –
- 7-point Likert scale: 1 = I strongly disagree – 7 = I strongly agree
- What month of the year were you born?
- –
- Odd (January, March, May, July, September, November) = Control group
- –
- Even (February, April, June, August, October, December) = Treatment group
- In your opinion, how effective – persuasive do you think the poster you just saw is?
- –
- 7-point Likert scale: 1 = Not persuasive at all – 7 = Extremely persuasive (answered only by the treatment group)
- Do you intend to avoid crowded indoor spaces or places that require close contact between people?
- Do you intend to prefer contactless payment methods (e.g. credit cards, mobile phone) over cash for your purchases?
- Do you intend to wear a mask properly, with your nose and mouth covered, indoors where required (e.g. in the supermarket, at work)?
- Do you intend to avoid kisses, handshakes and hugs?
- Do you intend to wash your hands often and carefully / or to apply antiseptic after touching potentially contaminated surfaces whenever possible (e.g. when returning home, at work)?
- Do you intend to avoid touching your eyes, nose and mouth, without washing your hands first?
- How important is it to you to act for the benefit of others and society as a whole, even if it may sometimes cost you (financially or otherwise)?
- –
- 7-point Likert scale: 1 = Not important at all – 7 = Extremely important
- To what extent do you feel that the individual preventive measures you are taking against COVID-19 really contribute to limiting the spread of the new coronavirus?
- –
- 7-point Likert scale: 1 = They do not contribute at all – 7 = They contribute a lot
References
- Hanoch, Y.; Barnes, A.; Rice, T. Behavioral Economics and Healthy Behaviors: Key Concepts and Current Research; Routledge, 2017.
- Thaler, R. H.; Sunstein, C. R. Nudge: Improving Decisions about Health, Wealth, and Happiness; Yale University Press, 2008.
- Advice for the public on COVID-19 – World Health Organization. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public (accessed 2023-10-26).
- Basher, S. A.; Haque, A. K. E. Public Policy Lessons from the Covid-19 Outbreak: How to Deal with It in the Post-Pandemic World? J. Soc. Econ. Dev. 2021, 23, 234–247. [Google Scholar] [CrossRef] [PubMed]
- Jordan, J. J.; Yoeli, E.; Rand, D. G. Don’t Get It or Don’t Spread It: Comparing Self-Interested versus Prosocial Motivations for COVID-19 Prevention Behaviors. Sci. Rep. 2021, 11, 20222. [Google Scholar] [CrossRef] [PubMed]
- Fehr, E.; Fischbacher, U. The Nature of Human Altruism. Nature 2003, 425, 785–791. [Google Scholar] [CrossRef] [PubMed]
- Betsch, C.; Böhm, R.; Korn, L.; Holtmann, C. On the Benefits of Explaining Herd Immunity in Vaccine Advocacy. Nat. Hum. Behav. 2017, 1(3), 1–6. [Google Scholar] [CrossRef]
- Li, M.; Taylor, E. G.; Atkins, K. E.; Chapman, G. B.; Galvani, A. P. Stimulating Influenza Vaccination via Prosocial Motives. PLOS ONE 2016, 11(7), e0159780. [Google Scholar] [CrossRef] [PubMed]
- Vietri, J. T.; Li, M.; Galvani, A. P.; Chapman, G. B. Vaccinating to Help Ourselves and Others. Med. Decis. Making 2012, 32(3), 447–458. [Google Scholar] [CrossRef]
- Isler, O.; Isler, B.; Kopsacheilis, O.; Ferguson, E. Limits of the Social-Benefit Motive among High-Risk Patients: A Field Experiment on Influenza Vaccination Behaviour. BMC Public Health 2020, 20(1), 240. [Google Scholar] [CrossRef] [PubMed]
- Bonafide, K. E.; Vanable, P. A. Male Human Papillomavirus Vaccine Acceptance Is Enhanced by a Brief Intervention That Emphasizes Both Male-Specific Vaccine Benefits and Altruistic Motives. Sex. Transm. Dis. 2015, 42(2), 76. [Google Scholar] [CrossRef]
- Grant, A. M.; Hofmann, D. A. It’s Not All About Me: Motivating Hand Hygiene Among Health Care Professionals by Focusing on Patients. Psychol. Sci. 2011, 22(12), 1494–1499. [Google Scholar] [CrossRef]
- Bhopal, S. S.; Bagaria, J.; Olabi, B.; Bhopal, R. Children and Young People Remain at Low Risk of COVID-19 Mortality. Lancet Child Adolesc. Health 2021, 5(5), e12–e13. [Google Scholar] [CrossRef]
- Utych, S. M.; Fowler, L. Age-Based Messaging Strategies for Communication about COVID-19. J. Behav. Public Adm. 2020, 3 (1). [CrossRef]
- Loewenstein, G. F.; Weber, E. U.; Hsee, C. K.; Welch, N. Risk as Feelings. Psychol. Bull. 2001, 127(2), 267–286. [Google Scholar] [CrossRef] [PubMed]
- Wildavsky, A.; Dake, K. Theories of Risk Perception: Who Fears What and Why? Daedalus 1990, 119(4), 41–60. [Google Scholar]
- Dryhurst, S.; Schneider, C. R.; Kerr, J.; Freeman, A. L. J.; Recchia, G.; van der Bles, A. M.; Spiegelhalter, D.; van der Linden, S. Risk Perceptions of COVID-19 around the World. J. Risk Res. 2020, 23 (7–8), 994–1006. [CrossRef]
- Sasaki, S.; Kurokawa, H.; Ohtake, F. Effective but Fragile? Responses to Repeated Nudge-Based Messages for Preventing the Spread of COVID-19 Infection. Jpn. Econ. Rev. 2021, 72 (3), 371–408. [CrossRef]
- Falco, P.; Zaccagni, S. Promoting Social Distancing in a Pandemic: Beyond Good Intentions. PLOS ONE 2021, 16(12), e0260457. [Google Scholar] [CrossRef] [PubMed]
- Campos-Mercade, P.; Meier, A. N.; Schneider, F. H.; Wengström, E. Prosociality Predicts Health Behaviors during the COVID-19 Pandemic. J. Public Econ. 2021, 195, 104367. [Google Scholar] [CrossRef] [PubMed]
- Favero, N.; Pedersen, M. J. How to Encourage “Togetherness by Keeping Apart” amid COVID-19? The Ineffectiveness of Prosocial and Empathy Appeals. J. Behav. Public Adm. 2020, 3 (2). [CrossRef]
- Levkovich, I. The Impact of Age on Negative Emotional Reactions, Compliance With Health Guidelines, and Knowledge About the Virus During the COVID-19 Epidemic: A Longitudinal Study From Israel. J. Prim. Care Community Health 2020, 11, 2150132720981540. [Google Scholar] [CrossRef] [PubMed]
- Monod, M.; Blenkinsop, A.; Xi, X.; Hebert, D.; Bershan, S.; Tietze, S.; Baguelin, M.; Bradley, V. C.; Chen, Y.; Coupland, H.; Filippi, S.; Ish-Horowicz, J.; McManus, M.; Mellan, T.; Gandy, A.; Hutchinson, M.; Unwin, H. J. T.; van Elsland, S. L.; Vollmer, M. A. C.; Weber, S.; Zhu, H.; Bezancon, A.; Ferguson, N. M.; Mishra, S.; Flaxman, S.; Bhatt, S.; Ratmann, O.; ON BEHALF OF THE IMPERIAL COLLEGE COVID-19 RESPONSE TEAM. Age Groups That Sustain Resurging COVID-19 Epidemics in the United States. Science 2021, 371 (6536), eabe8372. [CrossRef]
- Hellenic Parliament. Decision No. D1 a/GP.ok.3608/2022, Gazette 155/B/21-1-2022-Emergency measures to protect public health from the risk of further spread of the coronavirus COVID-19 throughout the Territory, for the period from Monday, January 24, 2022 at 6:00 a.m. until Monday, January 31, 2022 at 6:00 a.m. Gazette of the Government of the Hellenic Republic. Issue Two, No. Sheet 155/21-1-2022. January 22, 2022. https://www.e-nomothesia.gr/law-news/demosieutheke-kua-ten-paratase-ton-metron-eos-24-ianoyarioy-2022.html (accessed 2022-03-05).
- EODY. Daily Report of Epidemiological Surveillance of Infection by the Novel Coronavirus (COVID-19); EODY, 2022. https://eody.gov.gr/wp-content/uploads/2022/02/covid-gr-daily-report-20220201.pdf (accessed 2022-03-05).
- Dohmen, T.; Falk, A.; Huffman, D.; Sunde, U.; Schupp, J.; Wagner, G. G. Individual Risk Attitudes: Measurement, Determinants, and Behavioral Consequences. J. Eur. Econ. Assoc. 2011, 9(3), 522–550. [Google Scholar] [CrossRef]
- van der Linden, S. Determinants and Measurement of Climate Change Risk Perception, Worry, and Concern. Rochester, NY April 16, 2017. [CrossRef]
- Haushofer, J.; Metcalf, C. J. E. Combining Behavioral Economics and Infectious Disease Epidemiology to Mitigate the COVID-19 Outbreak. https://focusconsulenza.com/wp-content/uploads/2020/04/Haushofer_Metcalf_Corona_2020-03-06.pdf (accessed 2022-01-16).
- Zimmermann, B. M.; Fiske, A.; McLennan, S.; Sierawska, A.; Hangel, N.; Buyx, A. Motivations and Limits for COVID-19 Policy Compliance in Germany and Switzerland. Int. J. Health Policy Manag. 2022, 11(8), 1342–1353. [Google Scholar] [CrossRef] [PubMed]
- Kanellopoulou, A.; Koskeridis, F.; Markozannes, G.; Bouras, E.; Soutziou, C.; Chaliasos, K.; Doumas, M. T.; Sigounas, D. E.; Tzovaras, V. T.; Panos, A.; Stergiou, Y.; Mellou, K.; Papamichail, D.; Aretouli, E.; Chatzidimitriou, D.; Chatzopoulou, F.; Bairaktari, E.; Tzoulaki, I.; Evangelou, E.; Rizos, E. C.; Ntzani, E.; Vakalis, K.; Tsilidis, K. K. Awareness, Knowledge and Trust in the Greek Authorities towards COVID-19 Pandemic: Results from the Epirus Health Study Cohort. BMC Public Health 2021, 21(1), 1125. [Google Scholar] [CrossRef]
- Anderson, R. M.; Heesterbeek, H.; Klinkenberg, D.; Hollingsworth, T. D. How Will Country-Based Mitigation Measures Influence the Course of the COVID-19 Epidemic? The Lancet 2020, 395(10228), 931–934. [Google Scholar] [CrossRef]
- Barari, S.; Caria, S.; Davola, A.; Falco, P.; Fetzer, T.; Fiorin, S.; Hensel, L.; Ivchenko, A.; Jachimowicz, J.; King, G.; Kraft-Todd, G.; Ledda, A.; MacLennan, M.; Mutoi, L.; Pagani, C.; Reutskaja, E.; Roth, C.; Slepoi, F. R. Evaluating COVID-19 Public Health Messaging in Italy: Self-Reported Compliance and Growing Mental Health Concerns. medRxiv April 5, 2020, p 2020.03.27.20042820. [CrossRef]
- Public Health England. Disparities in the Risk and Outcomes of COVID-19; Public Health England, 2020. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/908434/Disparities_in_the_risk_and_outcomes_of_COVID_August_2020_update.pdf (accessed 2022-01-16).
- Ramkissoon, H. COVID-19 Place Confinement, Pro-Social, Pro-Environmental Behaviors, and Residents’ Wellbeing: A New Conceptual Framework. Front. Psychol. 2020, 11. [Google Scholar] [CrossRef] [PubMed]
- Wright, L.; Steptoe, A.; Mak, H. W.; Fancourt, D. Do People Reduce Compliance with COVID-19 Guidelines Following Vaccination? A Longitudinal Analysis of Matched UK Adults. J Epidemiol Community Health 2022, 76(2), 109–115. [Google Scholar] [CrossRef] [PubMed]
- Nese, M.; Riboli, G.; Brighetti, G.; Sassi, V.; Camela, E.; Caselli, G.; Sassaroli, S.; Borlimi, R. Delay Discounting of Compliance with Containment Measures during the COVID-19 Outbreak: A Survey of the Italian Population. J. Public Health 2022, 30(2), 503–511. [Google Scholar] [CrossRef] [PubMed]
- Sheeran, P.; Webb, T. L. The Intention–Behavior Gap. Soc. Personal. Psychol. Compass 2016, 10(9), 503–518. [Google Scholar] [CrossRef]
- Boserup, B.; McKenney, M.; Elkbuli, A. Disproportionate Impact of COVID-19 Pandemic on Racial and Ethnic Minorities. Am. Surg. 2020, 86(12), 1615–1622. [Google Scholar] [CrossRef]

| Nominal variables | Category | f | % |
|---|---|---|---|
| Personal history of COVID-19 |
Positive |
121 |
28.5 |
| Negative | 304 | 71.5 | |
| Family history of COVID-19 |
Positive |
219 |
51.5 |
| Negative | 206 | 48.5 | |
| Vulnerability to novel coronavirus |
Yes |
45 |
10.6 |
| No | 372 | 87.5 | |
| I don’t know | 8 | 1.9 | |
| Self-assessment of health status |
Very bad |
1 |
0.2 |
| Bad | 2 | 0.5 | |
| Moderate | 18 | 4.2 | |
| Good | 96 | 22.6 | |
| Very good | 193 | 45.4 | |
| Excellent | 115 | 27.1 | |
| COVID-19 vaccination status |
Vaccinated |
408 |
96.0 |
| Non-vaccinated | 17 | 4.0 |
| Item/Scale | Mean | S.D. | 95% CI lower | 95% CI upper |
|---|---|---|---|---|
| Use of mask* | 94.24 | 11.85 | 93.11 | 95.37 |
| Frequent handwashing* | 93.32 | 11.60 | 92.21 | 94.42 |
| Avoidance of overcrowding* | 87.41 | 18.89 | 85.61 | 89.21 |
| Avoidance of touching face mucosa* | 82.82 | 20.83 | 80.84 | 84.81 |
| Adoption of contactless transactions* | 84.52 | 19.81 | 82.63 | 86.41 |
| Avoidance of handshakes* | 88.38 | 17.39 | 86.72 | 90.03 |
| Worry about the pandemic | 59.57 | 25.72 | 57.12 | 62.02 |
| Personal chance of infection | 72.08 | 24.14 | 69.78 | 74.38 |
| Familial chance of infection | 77.61 | 20.31 | 75.67 | 79.54 |
| Assessment of virus spread | 89.76 | 14.22 | 88.41 | 91.12 |
| Understanding disease severity | 90.24 | 15.42 | 88.76 | 91.71 |
| Compliance** | 88.45 | 10.87 | 87.41 | 89.48 |
| Risk perception** | 77.85 | 13.32 | 76.58 | 79.12 |
| Intention** | 90.44 | 11.08 | 89.39 | 91.45 |
| General risk attitudes | 54.35 | 26.70 | 51.80 | 56.90 |
| Health risk attitudes | 30.99 | 28.43 | 28.28 | 33.70 |
| Prosociality | 82.16 | 17.84 | 80.46 | 83.86 |
| Personal efficacy | 87.73 | 16.08 | 86.19 | 89.26 |
| Variable | Control group | Treatment group | Z* | p-value |
|---|---|---|---|---|
| Compliance (A) | 88.74 | 88.16 | -0.348 | 0.728 |
| Intention (Β) Difference (Β) – (A) |
90.52 1.78 |
90.37 2.20 |
-0.284 -0.022 |
0.776 0.982 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).